Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06120790 · ClinicalTrials.gov registry record
Investigation of a 3 oz Water Protocol on Patients With Tracheostomies
A clinical trial of Tracheostomy, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT06120790 is a study of Tracheostomy that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 80 participants, above the 20-participant average among 3 other Tracheostomy trials with a reported enrollment target (300% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06120790, a study of Tracheostomy, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Examining the validity of a novel 3 oz protocol in patients with tracheostomies as compared to the gold standard of instrumental swallow assessments (Flexible Endoscopic Evaluation of the Swallow or Modified Barium Swallow Study).
Conditions Studied
Interventions
- OTHER 3 Oz water screen
Study Locations (1)
New York
- Mount Sinai Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-05-06 |
| Est. Completion | 2027-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06120790
The ClinicalTrials.gov registry entry for NCT06120790 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 20-participant average among 3 other Tracheostomy trials with a reported enrollment target (300% higher). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tracheostomy appearing as the primary indexed condition, and to 1 intervention - of which 3 Oz water screen is the first listed.
NCT06120790 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06120790 about?
NCT06120790 is a clinical study titled "Investigation of a 3 oz Water Protocol on Patients With Tracheostomies". Examining the validity of a novel 3 oz protocol in patients with tracheostomies as compared to the gold standard of instrumental swallow assessments (Flexible Endoscopic Evaluation of the Swallow or Modified Barium Swallow Study).
What is the current status of trial NCT06120790?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2024-05-06. Estimated completion is 2027-10.
What conditions does trial NCT06120790 study?
This clinical trial studies the following conditions: Tracheostomy.
What interventions are being tested in trial NCT06120790?
The interventions under investigation include: 3 Oz water screen (OTHER).
Who is sponsoring clinical trial NCT06120790?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06120790 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tracheostomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.